HRMY
Harmony Biosciences Holdings
39.60$
+0.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.2% | 25.6% | 17.8% | 18.6% | 23.0% | 27.0% | 17.3% | 19.0% | 24.9% | 28.1% | 20.7% | 24.2% | 24.6% | |
| 79.8% | 74.4% | 82.2% | 81.4% | 77.0% | 73.0% | 82.7% | 81.0% | 75.1% | 71.9% | 79.3% | 75.8% | 75.4% | |
| 10.9% | 18.0% | 14.4% | 36.8% | 13.6% | 17.2% | 18.7% | 25.0% | 23.0% | 20.5% | 32.2% | 17.8% | 23.0% | |
| 14.1% | 16.5% | 16.6% | 15.8% | 15.4% | 14.3% | 16.9% | 16.9% | 12.4% | 23.6% | 15.1% | 10.7% | 15.4% | |
| 39.6% | 50.5% | 48.6% | 69.0% | 43.8% | 45.3% | 52.2% | 56.9% | 47.7% | 56.1% | 62.0% | 41.6% | 51.4% | |
| 40.3% | 23.9% | 33.7% | 12.4% | 33.2% | 27.7% | 30.4% | 24.0% | 27.3% | 15.8% | 17.3% | 34.2% | 24.0% | |
| 4.4% | 2.8% | 2.9% | 2.5% | 2.3% | 2.1% | 2.1% | 1.8% | 1.5% | 1.5% | 1.5% | 1.2% | 1.4% | |
| 32.3% | 23.6% | 33.5% | 12.6% | 33.4% | 27.9% | 31.0% | 24.8% | 28.2% | 16.7% | 18.4% | 35.7% | 25.1% | |
| 8.3% | 7.8% | 8.7% | 5.8% | 8.6% | 3.3% | 6.3% | 4.9% | 6.9% | 7.5% | 3.3% | 6.8% | 6.2% | |
| 24.0% | 15.8% | 24.8% | 6.7% | 24.8% | 24.6% | 24.7% | 19.8% | 21.2% | 9.2% | 15.1% | 28.9% | 18.9% | |
| 40.5% | 36.4% | 40.4% | 18.6% | 39.0% | 33.0% | 36.3% | 29.6% | 30.7% | 21.2% | 22.7% | 39.2% | 28.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.